Search clinical trials for: subcutaneous insulin

Total 10099 results

McGill University Health Centre/Research Institute...

Not yet recruiting

Alleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide (SEMA SMA)

Diabetes Mellitus | Type 1 Diabetes

Canada
Vastra Gotaland Region
Göteborg University

Recruiting

Adaptive Mechanisms In GRown up ObeSity Study (AMIGROS) (AMIGROS)

Obesity | Type 2 Diabetes

Sweden
Mayo Clinic

Not yet recruiting

Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

Type 1 Diabetes

United States
First Affiliated Hospital of Guangxi Medical University

Recruiting

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Type2diabetes

China
Changhua Christian Hospital

Recruiting

Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care

Diabetic Ketoacidosis | Hyperglycaemic Crisis in Diabetes Mellitus | Hyperglycaemic Hyperosmolar Nonketotic Syndrome

Taiwan
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

LNK in Polycystic Ovary Syndrome With Insulin Resistance

Insulin Resistance | Polycystic Ovarian Syndrome

China
Ministry of Health, Saudi Arabia

Not yet recruiting

The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions (COVID-19)

Taste Disorders | Smell Disorder | Smell Dysfunction | Taste Disorder, Secondary, Sweet | Taste Disorder, Secondary, Bitter
Peking University Third Hospital

Not yet recruiting

CSII Versus MDI in Pregnant Women With Type 2 Diabetes

Type 2 Diabetes | Pregnancy in Diabetic

China
VitalAire

Not yet recruiting

Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life (IMPLIQUE)

Quality of Life | Burden, Dependency
Pennington Biomedical Research Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding (EAT 2)

Metabolic Syndrome | Overweight and Obesity

United States
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes (DSS-2)

Diabetes Mellitus, Type 1

United States
University Hospital, Montpellier
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaborators

Recruiting

Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia (DCLP2)

Type 1 Diabetes Mellitus With Hypoglycemia

France
Chinese University of Hong Kong

Recruiting

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Diabetes Mellitus | Insulin Resistance | Obesity, Morbid | Non-Alcoholic Fatty Liver Disease | Metabolic Disease | Brown Fat | Abdominal Subcutaneous Fat

Hong Kong
Medical University of Graz

Recruiting

Inflammatory Response to CSII Catheters in a Tummy Tuck Model (IRCATT)

Diabetes Mellitus

Austria
Sun Yat-sen University
Guangdong Provincial Hospital of Traditional Chinese Medicine; The Third Affiliated... and other collaborators

Recruiting

Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
University of Cambridge
The Leeds Teaching Hospitals NHS Trust; Cambridge University Hospitals NHS... and other collaborators

Active, not recruiting

Closed Loop From Onset in Type 1 Diabetes (CLOuD)

Diabetes Mellitus | Type 1 Diabetes

United Kingdom
Wake Forest University Health Sciences

Completed

CGM Utilization With IV Insulin EndoTool and Subcutaneous Insulin in the Neuro ICU

Hyperglycemia | Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
McGill University Health Centre/Research Institute...

Active, not recruiting

Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care (SEMA-AP)

Diabetes Mellitus, Type 1 | Type 1 Diabetes

Canada
Imperial College London
London Ambulance Service

Terminated

Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia (AIR-CGM)

Hypoglycemia | Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United Kingdom
The University of Texas Health Science Center at...

Suspended

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Type 2 Diabetes | Insulin Sensitivity | Glucose Tolerance Impaired

United States
University Hospital, Basel, Switzerland

Active, not recruiting

Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes (Hypo-PrEA)

Postprandial Hypoglycemia

Switzerland
Nemours Children's Clinic
Patient-Centered Outcomes Research Institute

Completed

Shared Medical Decision Making in Pediatric Diabetes

Type 1 Diabetes Mellitus

United States
Amphastar Pharmaceuticals, Inc.

Completed

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers

Pharmacokinetics | Pharmacodynamics

United States
The Cleveland Clinic
Novo Nordisk A/S

Completed

Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With Type-2 Diabetes Mellitus (TRANSITION-T2D)

Type 2 Diabetes

United States
Hospital de Clinicas de Porto Alegre

Completed

Reusing Needles for Subcutaneous Insulin Injection in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Brazil
Marc Breton
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery (Rocket-BPS)

Type 1 Diabetes

United States
Stanford University
American Heart Association

Enrolling by invitation

Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance

Inflammation | Obesity | Insulin Resistance | Insulin Sensitivity

United States
Washington University School of Medicine
Janssen Scientific Affairs, LLC

Completed

Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism (ADIPOSITY)

Adiposity | HIV I Infection

United States
Nemours Children's Clinic

Completed

Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)

Diabetes Mellitus, Insulin-Dependent

United States
Gianna Wilkie

Completed

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

Type 1 Diabetes | Pregnancy, High Risk

United States
Eli Lilly and Company

Completed

A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1

Canada
Novo Nordisk A/S

Completed

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works

Diabetes Mellitus, Type 1

Austria
Mannkind Corporation

Completed

Afrezza With Basal Combination (ABC)

Type 1 Diabetes

United States
University Hospital, Caen

Completed

Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes

Type 2 Diabetes Mellitus
Arecor Limited

Completed

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

Diabetes Mellitus, Type 1

United States
Capillary Biomedical, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Integrated... and other collaborators

Completed

Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")

Diabetes Mellitus, Type 1 | Type 1 Diabetes

United States
Federico II University

Terminated

Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward (Initiator)

Diabetes Mellitus | Covid19

Italy
Boston Children's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Heart And Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT)

Heart Failure | Respiratory Failure

United States, Australia, Canada
Benha University

Completed

Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

COVID-19 | Dysglycemia

Egypt
Sanofi

Completed

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus

Germany
Sanofi

Completed

Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients

Type 1 Diabetes Mellitus

United States
University of Maryland, Baltimore

Completed

Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis

Diabetic Ketoacidosis

United States
Kinderkrankenhaus auf der Bult

Completed

Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update (UNIQUE)

Type 1 Diabetes | Insulin Therapy

Germany
Ypsomed AG
Diabetes Center Berne Research AG

Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Diabetes Mellitus, Type 1

Germany, Switzerland
Castilla-La Mancha Health Service
Spanish Diabetes Association

Completed

Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain

Type 1 Diabetes

Spain
University of Colorado, Denver
Novo Nordisk A/S

Completed

Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy

Diabetes

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion

Type 1 Diabetes

United States
Pennington Biomedical Research Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women (Apple/Pear)

Obesity | Metabolic Syndrome

United States
Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes

Diabetes | Type 2 Diabetes Mellitus

Germany
Mountain Diabetes and Endocrine Center
Novo Nordisk A/S

Completed

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump (BIG LEAP)

Type1 Diabetes Mellitus

United States

Search clinical trials for: subcutaneous insulin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations